Accounts Payable - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Accounts Payable Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Accounts Payable
€5.6m
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Accounts Payable
€8.5m
CAGR 3-Years
-51%
CAGR 5-Years
-11%
CAGR 10-Years
-1%
Nanobiotix SA
PAR:NANO
Accounts Payable
€173k
CAGR 3-Years
N/A
CAGR 5-Years
-52%
CAGR 10-Years
-19%
Innate Pharma SA
PAR:IPH
Accounts Payable
€15.9m
CAGR 3-Years
12%
CAGR 5-Years
-7%
CAGR 10-Years
5%
Genfit SA
NASDAQ:GNFT
Accounts Payable
€10.4m
CAGR 3-Years
-20%
CAGR 5-Years
-20%
CAGR 10-Years
7%
Eurobio Scientific SA
PAR:ALERS
Accounts Payable
€13m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
12%

See Also

What is Gensight Biologics SA's Accounts Payable?
Accounts Payable
5.6m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Accounts Payable amounts to 5.6m EUR.

What is Gensight Biologics SA's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-6%

Over the last year, the Accounts Payable growth was -28%. The average annual Accounts Payable growth rates for Gensight Biologics SA have been -9% over the past three years , -6% over the past five years .

Back to Top